Protagonist Therapeutics, Inc. earnings per share and revenue

PTGX earnings per share for the last quarter are 0.44 USD whereas the estimation was 0.05 USD which accounts for 720.64% surprise. Company revenue for the same period amounts to 60.00 M USD despite the estimated figure of 60.00 M USD. Estimated earnings per share for the next quarter are 1.19 USD, and revenue is expected to reach 180.00 M USD. Also watch annual changes over time to get a bigger picture of PTGX earnings per share and revenue dynamics.